VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
VERACYTE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$43.80+0.68 (+1.58%)
Close on Oct 19, 2026
- Market cap
- $3.59B
- P/E (TTM)
- 31.3
- Dividend yield
- –
Veracyte statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Veracyte | Industry median |
|---|---|---|
| Market Cap | $3.52B | $1.11B |
| Enterprise Value | $3.22B | $1.41B |
| PE Ratio | 31.29 | 22.72 |
| PS Ratio | 6.27 | 1.60 |
| PB Ratio | 2.54 | 3.03 |
| P/TBV Ratio | 6.54 | 4.99 |
| P/FCF Ratio | 21.21 | 20.54 |
| P/OCF Ratio | 19.74 | 15.44 |
Enterprise value
| Measure | Veracyte | Industry median |
|---|---|---|
| EV / Sales | 5.73 | 1.69 |
| EV / EBITDA | 25.45 | 14.40 |
| EV / EBIT | 30.46 | 19.04 |
| EV / FCF | 19.41 | 23.16 |
Income (trailing twelve months)
| Measure | Veracyte | Industry median |
|---|---|---|
| Revenue | $561.90M | $561.90M |
| Gross Profit | $402.96M | $173.32M |
| Operating Income | $105.77M | -$1.81M |
| Pretax Income | $116.02M | -$572.42K |
| Net Income | $114.48M | -$1.16M |
| EBITDA | $126.60M | -$20.72K |
| EPS (Diluted) | $1.40 | -$0.02 |
Margins
| Measure | Veracyte | Industry median |
|---|---|---|
| Gross Margin | 71.7% | 33.1% |
| Operating Margin | 18.8% | -4.45% |
| Pretax Margin | 20.6% | 1.54% |
| Profit Margin | 20.4% | -2.91% |
| EBITDA Margin | 22.5% | 2.41% |
| FCF Margin | 29.5% | 3.13% |
Returns
| Measure | Veracyte | Industry median |
|---|---|---|
| Return on Equity (ROE) | 8.77% | 1.84% |
| Return on Assets (ROA) | 8.09% | -3.06% |
| Return on Invested Capital (ROIC) | 9.99% | 2.11% |
| Return on Capital Employed (ROCE) | 7.43% | -0.57% |
Growth
| Measure | Veracyte | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 17.3% | 6.92% |
| Net Income Growth (YoY) | 334.7% | 19.6% |
| EPS Growth (YoY) | 324.2% | 25.8% |
| FCF Growth (YoY) | 97.7% | -6.04% |
| Revenue Growth (3Y CAGR) | 20.4% | 10.9% |
| Revenue Growth (5Y CAGR) | 34.5% | 13.2% |
Balance sheet
| Measure | Veracyte | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $299.52M | $48.71M |
| Net Cash (Debt) | $299.52M | $205.49K |
| Net Cash Per Share | $3.73 | $0.01 |
| Equity (Book Value) | $1.39B | $235.16M |
| Book Value Per Share | $17.27 | $3.48 |
| Tangible Book Value | $538.55M | $703.69K |
| Working Capital | $512.04M | $30.48M |
Financial position
| Measure | Veracyte | Industry median |
|---|---|---|
| Current Ratio | 9.16 | 1.40 |
| Quick Ratio | 5.64 | 1.02 |
Cash flow (trailing twelve months)
| Measure | Veracyte | Industry median |
|---|---|---|
| Operating Cash Flow | $178.38M | $3.10M |
| Capital Expenditures | -$12.39M | -$18.62M |
| Free Cash Flow | $165.99M | $23.73M |
| FCF Per Share | $2.06 | $0.37 |
Efficiency
| Measure | Veracyte | Industry median |
|---|---|---|
| Asset Turnover | 0.40 | 0.87 |
| Inventory Turnover | 6.35 | 11.67 |
| Revenue Per Employee | $744.24K | $228.48K |
| Profits Per Employee | $151.63K | -$5.75K |
| Employee Count | 755 | 910 |
Dividends and yields
| Measure | Veracyte | Industry median |
|---|---|---|
| Earnings Yield | 3.25% | -0.59% |
| FCF Yield | 4.71% | 1.74% |
Shares
| Measure | Veracyte | Industry median |
|---|---|---|
| Shares Outstanding | 80,390,700 | 58,282,400 |
| Shares Change (YoY) | 2.51% | 2.68% |
| Shares Change (QoQ) | 0.72% | 0.32% |
| Float | 79,016,800 | 33,780,100 |
| Shares Held by Insiders | 1.71% | 16.4% |
| Shares Held by Institutions | 110.9% | 85.9% |
Taxes
| Measure | Veracyte | Industry median |
|---|---|---|
| Income Tax | $1.54M | $697.00K |
| Effective Tax Rate | 1.32% | 23.1% |
Scores
| Measure | Veracyte | Industry median |
|---|---|---|
| Graham Number | $23.32 | $19.59 |
| Graham Upside | -46.7% | -47.5% |
| Altman Z-Score | 22.29 | 2.05 |
| Piotroski F-Score | 7 | 5 |
| Beneish M-Score | -2.67 | -2.71 |
Calculated by StockData from Veracyte's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.